DETERMINING THE FREQUENCY FACTORS OF CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS
DOI:
https://doi.org/10.11603/2415-8798.2017.1.7326Keywords:
ankylosing spondylitis, cardiovascular risk.Abstract
Ankylosing spondylitis is an illnes in which there is a damage to the musculoskeletal system. Mortality among patients with AS is 1.5 times higher than population levels. It is caused by cardio-vascular disease and chronic renal failure.
The aim of the study – to stratificate factors of cardiovascular risk.
Materials and Methods. We examined 104 patients with ankylosing spondylitis (AS) using standard diagnostic methods such as the activity of the disease, lipidogram and ultrasound of intimal media of the carotid artery. Inclusion criteria in the study were: diagnosis of AS according to the modified New York criteria and an informative patient's consent to participate in the study. Exclusion criteria in the study were: age over 60 years, the presence of psoriasis, Crohn's disease, ulcerative colitis, coronary heart disease, manifest peripheral atherosclerosis, clinically significant heart disease, circulatory insufficiency of any origin, diabetes, severe liver disease, kidney disease and other chronic diseases in their acute phases. Clinical activity of the illness was determined using the disease activity index BASDAI, BASFI functional index, an index BASMI metrology, quality of life ASQoL. To assess the 10-year risk of cardiovascular disease, the scale QRISK was used.
Results and Discussion. It was discovered that in the conditions of the higher degrees of disease activity the incidence of patients often occurs with LPL > 1.7 mg / dL, HDL-C <1.0 mmol / L, TIM thickening >0.9 mm. There was significant prolongation of the disease in this group of patients and a substantial difference in their progress in terms of VAS, CRP, ESR, index activity and functional disorders.
Conclusions. We must assume that the problem of CVD in patient with AS is a result of systemic inflammatory disease which is associated with the development of endothelial dysfunction and increased levels of atherogenic lipids.
References
Braun, J., & Sieper, J. (2007). Ankylosing spondylitis. Lancet, 369, 1379-1390.
Braun, J., van den Berg R. (2010). Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann. Rheum. Dis, 70, 896-904.
Brown, M.A., & Kenna, T.T. (2016). Genetics of ankylosing spondylitis-insights into pathogenesis. Nat. Rev. Rheumatol, 12, 81-91.
Chen, H.A., Chen, C.H., & Liao, H.T. (2012). Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J. Rheumatol., 39, 3-8.
Erre, G.L., Sanna, P., & Zinellu, A. (2011). Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study. Clin. Rheumatol., 30, 21-27.
Heeneman, S., Daemen, M.J. (2017). Cardiovascular risks in spondyloarthritides. Curr. Opin. Rheumatol., 19, 358-362.
Kumar, A., & Falodia, S.K. (2009). Assessment of serum nitrite as biomarker of disease activity in ankylosing spondylitis. Indian J. Rheumatology, 4, 47-50.
McCarey, D., Sturrock, R.D. (2009). Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin. Exp. Rheumatol., 27, 124-126.
Celermajer, D.S., Sorensen, K.E., & Gooch, V.M. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 340, 1111-1115.
Poddubnyĭ, D.A. (2007). Endothelial dysfunction in patients with Bechterew’s disease (ankylosing spondylitis). Klin. Med. (Mosk), 85, 66-69.
Syngle, A., Vohra, K., Sharma, A., & Kaur, L.
Downloads
Published
How to Cite
Issue
Section
License
Authors who sent their manuscript to "Вісник наукових досліджень. Bulletin of Scientific Research" Surgery agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)